Adalat cc and Occlusion - renal artery - a phase IV clinical study of FDA data

Summary:

Occlusion - renal artery is found among people who take Adalat cc, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Adalat cc and have Occlusion - renal artery. It is created by eHealthMe based on reports of 4,789 people who have side effects when taking Adalat cc from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 29, 2023

4,789 people reported to have side effects when taking Adalat cc.
Among them, 10 people (0.21%) have Occlusion - renal artery.


What is Adalat cc?

Adalat cc has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 4,894 Adalat cc users for its effectiveness, alternative drugs and more.

What is Occlusion - renal artery?

Occlusion - renal artery (a blockage of the major arteries that supply blood to the kidneys) is found to be associated with 1,225 drugs and 704 conditions by eHealthMe.

Number of Adalat cc and Occlusion - renal artery reports submitted per year:

Could Adalat cc cause Occlusion - renal artery?

Gender of people who have Occlusion - renal artery when taking Adalat cc *:

  • female: 40 %
  • male: 60 %

Age of people who have Occlusion - renal artery when taking Adalat cc *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Adalat cc *:

  1. Norvasc: 5 people, 50.00%
  2. Avapro: 4 people, 40.00%
  3. Lasix: 4 people, 40.00%
  4. Prevacid: 4 people, 40.00%
  5. Rasilez: 3 people, 30.00%
  6. Micardis: 3 people, 30.00%
  7. Zocor: 3 people, 30.00%
  8. Toprol-Xl: 3 people, 30.00%
  9. Vioxx: 3 people, 30.00%
  10. Halcion: 2 people, 20.00%

Common side effects people have besides Occlusion - renal artery *:

  1. Chest Pain: 4 people, 40.00%
  2. Gastritis (inflammation of stomach): 3 people, 30.00%
  3. Otitis Media (inflammation of the middle ear): 3 people, 30.00%
  4. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 30.00%
  5. Haematochezia (passage of stools containing blood): 3 people, 30.00%
  6. Haemorrhoids (a swollen vein or group of veins in the region of the anus): 3 people, 30.00%
  7. Heart Attack: 3 people, 30.00%
  8. Carotid Artery Stenosis (narrowing of carotid artery): 3 people, 30.00%
  9. Hyperkalemia (damage to or disease of the kidney): 3 people, 30.00%
  10. Joint Pain: 3 people, 30.00%

Common conditions people have *:

  1. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 30.00%
  2. Constipation: 3 people, 30.00%
  3. Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 2 people, 20.00%
  4. Hyperkalemia (damage to or disease of the kidney): 2 people, 20.00%
  5. Pain: 1 person, 10.00%
  6. Depression: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Adalat cc and have Occlusion - renal artery?

Check whether Occlusion - renal artery is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Occlusion - renal artery and when was it recovered:

Expand to all the drugs that have ingredients of nifedipine:

Alternative drugs to, pros and cons of Adalat cc:

Common Adalat cc side effects:

Browse all side effects of Adalat cc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Occlusion - renal artery treatments and more:

COVID vaccines that are related to Occlusion - renal artery:

Common drugs associated with Occlusion - renal artery:

All the drugs that are associated with Occlusion - renal artery:

Common conditions associated with Occlusion - renal artery:

All the conditions that are associated with Occlusion - renal artery:

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Adalat cc) and Adalat cc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: